Qube Research & Technologies LTD Atri Cure, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Atri Cure, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 22,019 shares of ATRC stock, worth $841,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,019
Previous 214,232
89.72%
Holding current value
$841,125
Previous $6.52 Million
92.31%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
48.8MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$176 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$161 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$107 Million0.5% of portfolio
-
Macquarie Group LTD Australia, C32MShares$76.3 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.77B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...